HomeMolecuLight Inc.

MolecuLight Inc.

MolecuLight Reports 10 Clinical Posters and Video Presentations at SAWC

"We are thrilled to have had a record number of MolecuLight-based clinical posters and presentations, from so many wound care professionals and settings, be included at the SAWC's Virtual Session", says Anil Amlani, MolecuLight's CEO.

MolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting

The i:X Surgical Sleeve provides a great opportunity for surgeons to fully utilize the diagnostic abilities of the MolecuLight imaging device for wound bed preparation, ensuring the wound bed is appropriate for graft application by repeating imaging after debridement and by allowing targeted and focused debridement revision to ideally maximize graft utilization and outcomes.

MolecuLight i:X ® Upgrade Enables Faster, More Accurate Digital Wound Measurement

Specifically, clinicians can now reliably detect more complex wound borders using the i:X's Auto Mode feature and can also now input a depth measurement.

MolecuLight Secures $7.5 million USD Term Loan from Oxford Finance LLC,

The financing will further support MolecuLight's commercial expansion for the growing global demand for its MolecuLight i:X device.